Entecavir Monohydrate CAS 209216-23-9 API Factory High Quality Antiviral Hepatitis B Infection
Mugadziri Wekutengesa ane Kuchena Kwepamusoro uye Hunhu Hwakagadzikana
Zita reKemikari: Entecavir Monohydrate
CAS: 209216-23-9
Inoshandiswa mukurapa Hepatitis B Infection
API High Quality, Commercial Production
Chemical Name | Entecavir Monohydrate |
Mashoko anoreva zvakafanana | Entecavir Hydrate;9 - [(1S,3R,4S) -4-Hydroxy-3-(hydroxymethyl) -2-methylenecyclopentyl]guanine Monohydrate |
Nhamba yeCAS | 209216-23-9 |
Nhamba yeCAT | RF-API79 |
Stock Status | MuStock, Kugadzirwa Kunokwira Kusvika Mazana emaKilogram |
Molecular Formula | C12H17N5O4 |
Molecular Weight | 295.3 |
Melting Point | >220℃ |
Density | 1.81 |
Shipping Condition | Yakatumirwa Pasi peAmbient Temperature |
Brand | Ruifu Chemical |
Item | Zvinotsanangurwa |
Chitarisiko | Ichena kana Inenge Yakachena Crystalline Powder |
Solubility | Yakasununguka Soluble muDimethylformamide, Inonyungudika Zvishoma Mumvura, Ethanol uye Methanol |
Kuzivikanwa IR | Spectrum yemuenzaniso inoenderana neyereferensi mwero |
Kuzivikanwa HPLC | Nguva yekuchengeta yemuenzaniso webvunzo inoenderana neiyo yereferensi mwero |
Mvura Yemukati (neKF) | 5.5% ~ 6.5% |
Specific Optical Rotation | +24.0° kusvika +30.0° (DMF: MeOH=1:1 C=1%) (pachinhu chisina mvura) |
Residue paIgnition | ≤0.10% |
Related Substances | |
Furoentecavir | ≤0.10% |
Entecavir 1-Epimer | ≤0.10% |
Entecavir 3-Epimer | ≤0.10% |
8-Methyoxy Entecavir | ≤0.10% |
Entecavir 4-Epimer | ≤0.10% |
8-Hydroxy Entecavir | ≤0.10% |
4-Dimethylsilyl Entecavir | ≤0.10% |
Entecavir Inoenderana Musanganiswa A | ≤0.10% |
Chero Kusachena Kusina Kutaurwa | ≤0.10% |
Zvose Zvisina Kuchena | ≤0.30% |
Residual Solvents | |
Methanol | ≤600ppm |
Dichloromethane | ≤300ppm |
Ethyl Acetate | ≤1000ppm |
Tetrahydrofuran | ≤720ppm |
Toluene | ≤890ppm |
Benzyl Chloride | ≤1000ppm |
Benzyl Doro | ≤1000ppm |
Microbial Limit | |
Total Aerobic Counts | ≤100cfu/g |
Mbiriso uye Molds | ≤10cfu/g |
Escherichia Coli | Haifaniri Kuonekwa |
Heavy Metals | ≤10ppm |
Assay | 98.0% ~ 102.0% (HPLC; pane anhydrous basis) |
Particle Size | 95% yezvikamu zvinofanirwa kunge zviri mukati me125um |
Test Standard | Enterprise Standard;United States Pharmacopoeia (USP) Standard |
Usage | Antiviral mushonga unoshandiswa mukurapa Hepatitis B Infection |
Package: Bhodhoro, Aluminium foil bag, Cardboard dhiramu, 25kg/Drum, kana zvinoenderana nezvinodiwa nemutengi.
Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza, mwando uye tumbuyu.
Entecavir Monohydrate (CAS 209216-23-9) inonzi antiviral drug inoshandiswa mukurapa Hepatitis B Virus (HBV) utachiona.Entecavir Monohydrate inonzi nucleoside analog (kunyanya, guanine analogue) iyo inhibits reverse transcription, DNA replication uye kunyora muvira.Iro rudzi rutsva rwe cyclopentyl acyl guanosine anti-Hepatitis B utachiona hwemishonga nemishonga yayo yemishonga yakafanana neEntecavir.Inoshandiswa kuchipatara pakurapa kwevakuru Chronic Hepatitis B umo mune kushingaira kwevhairasi kudzokorora, kuwedzera serum transaminase ALT kana maronda anoshanda anoratidzwa kubva pachiropa histology.Entecavir Monohydrate ine simba uye inosarudza inhibitor yeHBV, ine EC50 ye3.75 nM muHepG2 cell.Entecavir inonzi reverse transcriptase inhibitor.Inodzivirira Hepatitis B Virus (HBV) kuti isawanda uye inoderedza huwandu hwehutachiona mumuviri.